Selvita
San Bruno, CA, United States selvita.com From their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
Selvita is a European CRO supporting pharma, biotech, and agrochemical clients with drug discovery, drug development, and contract testing services. It works from sites in Poland and Croatia, with offices in the U.K. and the U.S., and supports projects from target validation through clinical development.
Services
Drug discovery
Provides discovery services from target validation to preclinical candidate nomination as standalone studies or integrated programs.
Integrated drug discovery programs
Coordinates interdisciplinary discovery projects with dedicated project management and scientific continuity across the discovery process.
Computer-aided drug design and AI
Uses structural biology, molecular modeling, AI, and machine learning for design, virtual screening, bioinformatics, and data interpretation.
Small molecule drug discovery
Supports small-molecule discovery across target discovery and validation, hit identification, hit-to-lead, lead optimization, and preclinical candidate stages.
Antibody discovery
Combines phage display, in vivo immunization, and hybrid approaches to identify antibodies for therapeutic, diagnostic, and research applications.
Antigen design and validation
Designs recombinant proteins and cell-based antigens and performs functional validation for antibody discovery workflows.
Antibody production
Produces recombinant antibodies in CHO or HEK systems with purification and quality control for screening and preclinical use.
Protein production
Target binding determination
Measures antibody-target binding by yes/no screening, affinity, and kinetic profiling using BLI, SPR, and MST.
22 more services
- Initial-stage developability
- Affinity maturation and sequence optimization
- Peptide drug discovery
- Small molecule analytical development and CMC services
- API, raw material, and drug product development
- Extractables and leachables testing
- Regulatory affairs support
- Target validation
- Medicinal and synthetic chemistry
- Structure-based drug design
- AI-based virtual screening
- Protein production and purification
- Protein characterization and quality control
- X-ray crystallography
- Cryo-EM
- In vitro assays and models
- Target engagement
- Target deconvolution and mechanism of action
- In vitro safety
- Cellular and biochemical assays
- High-throughput screening (HTS)
- In vivo models
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Antibody
- ADC
- Peptide
- Oligonucleotide
- Recombinant protein
5 more
- Toxicology
- In vivo
- HTS
- LC-MS/MS
- Biochemical assays
- Capacity
- 0.1 mg to 1 g
- Over 950 employees
- Almost 4,000 m2 of new laboratory space
- Two research sites in Krakow
- Scales
- Milligram · Gram
- Data supplied
- LC-MS · HPLC
Equipment
- Biolayer Interferometry (BLI)
- Surface Plasmon Resonance (SPR)
- Microscale Thermophoresis (MST)
- HR-LCMS
- GC-MS/MS
- ICP-MS
8 more
- ICP-OES
- HIC-HPLC
- SEC-HPLC
- nanoDSF
- LC-MS/MS
- HRMS
- X-ray crystallography
- Cryo-EM
Materials
- CHO cells
- Insect cells
- Primary human cells
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: drug development, analytical testing, manufacturing, and EU batch release
GLPSelf-reported
Scope: drug development and testing
Company
- Type
- CRO
- Founded
- 2007
- Team
- Over 950 employees
Locations
- Based in
- San Bruno, CA, United States
- Sites
- Krakow, Poland
- Wroclaw, Poland
- Poznan, Poland
- Zagreb, Croatia
- Boston, USA
- San Francisco, USA
- Cambridge, United Kingdom
- Serves
- Europe, European market, global, U.K., U.S.